VeriMomchamomilla recutita flower/leaf extract é seguro durante a gravidez?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
Pregnancy-safe products containing chamomilla recutita flower/leaf extract
Related ingredients
Frequently asked questions
- chamomilla recutita flower/leaf extract é seguro durante a gravidez?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
- chamomilla recutita flower/leaf extract é seguro durante a amamentação?
- Same rationale as pregnancy: no regulatory reproductive classification or CIR/SCCS contraindication for topical cosmetic use. Low but measurable maternal dermal absorption is possible; systemic transfer into milk is not demonstrated for cosmetic topical use. Breastfeeding exposure therefore scored as low (e=1).
- chamomilla recutita flower/leaf extract é seguro para a pele do bebê?
- No infant-specific safety signals or regulatory reproductive/ developmental classifications. Because infant skin has a higher surface-area-to-weight ratio and a less mature barrier, exposure score is increased by +1 versus adults (adult e=1 → infant e=2), although there are no data showing specific harm to 0–3 year olds from topical chamomile extracts used cosmetically. CIR assessment supports safety as used.
- Como o VeriMom pontua chamomilla recutita flower/leaf extract?
- O VeriMom pontua chamomilla recutita flower/leaf extract em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a chamomilla recutita flower/leaf extract na gravidez?
- Veja nossa lista curada de alternativas seguras a chamomilla recutita flower/leaf extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.